Publications by authors named "Jake Naumann"
Background: Differentiated thyroid cancer (DTC) affects thousands of lives worldwide each year. Typically, DTC is a treatable disease with a good prognosis. Yet, some patients are subjected to partial or total thyroidectomy and radioiodine therapy to prevent local disease recurrence and metastasis.
View Article and Find Full Text PDFArticle Synopsis
- - Differentiated thyroid cancer (DTC) is generally treatable, but some patients undergo aggressive treatments like thyroidectomy and radioiodine therapy, which can negatively impact their quality of life and may not be necessary for less aggressive cases.
- - A new multi-omics model has been proposed to better diagnose DTC by differentiating between normal thyroid tissue and tumors, particularly in papillary thyroid cancer (PTC), by analyzing various biological markers.
- - The study suggests that analyzing DNA mutations, telomere length, and metabolic profiles of thyroid tissues could lead to more effective patient management and avoid unnecessary treatments through targeted molecular approaches.